E K. Tarkiainen
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics.
Journal: Clinical pharmacology and therapeutics
Published: September 12, 2024
Value of Pharmacogenetic Testing Assessed with Real-World Drug Utilization and Genotype Data.
Journal: Clinical pharmacology and therapeutics
Published: June 08, 2024
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP.
Journal: Clinical pharmacology and therapeutics
Published: November 18, 2023
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
Journal: Human genomics
Published: November 02, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
Journal: Clinical pharmacology and therapeutics
Published: August 04, 2023
Genomewide Association Study of Simvastatin Pharmacokinetics.
Journal: Clinical pharmacology and therapeutics
Published: April 01, 2022
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics.
Journal: British journal of clinical pharmacology
Published: March 26, 2022
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.
Journal: Clinical pharmacology and therapeutics
Published: December 08, 2021
CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel.
Journal: Clinical pharmacology and therapeutics
Published: March 19, 2018
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions .
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: August 21, 2017
Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.
Journal: Basic & clinical pharmacology & toxicology
Published: June 21, 2017
Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
Journal: British journal of clinical pharmacology
Published: February 06, 2015
Last Updated: 09/26/2026